Abstract:In this issue of the Journal, Verhoeven and colleagues (1) further document the association between depressive and anxiety disorders and shorter leukocyte telomere length (LTL), an indicator of cellular aging. The researchers, reporting data from 2,936 participants in the Netherlands Study of Depression and Anxiety (NESDA) (2), observed that participants with remitted and with current depressive and anxiety disorders show shorter LTL than never-affected controls across baseline and 6-year follow-up. The researchers controlled for lifestyle and somatic health variables known also to affect telomere length. As illustrated in Figure 2 of their report, the longitudinal course of illness over 6 years (e.g., new onset, persistent remission, relapse, chronic) was not associatedwith differences in LTL attrition rates. The investigators conclude that short LTL could be either a long-term consequence (“imprint”) of depression and anxiety or a biomarker of an underlying vulnerability factor for these commonmental disorders. The studywas not designed to address this conundrum conclusively. What is new about this study is its focus on the longitudinal course of illness and LTL attrition. In a previous crosssectional report published in Molecular Psychiatry and addressing depression and accelerated cellular aging (3), the investigators observed significantly shorter LTL in both currently depressed (5,461 base pairs) and remitted (5,459 base pairs) patients compared with controls (5,541 base pairs). These differences in length were estimated to be the equivalent of 4–6 years of accelerated physiologic—not chronologic—aging. As in the current study, the large sample size of NESDA participants permitted control for potential confounders such as smoking, body mass index, alcohol use, and physical activity. In the Molecular Psychiatry report, the investigators reported evidence of a dose-response gradient: both depression severity and duration of depressive symptoms in the previous 4 years were associated with shorter telomeres. That relationship appears not to have been confirmed in the current longitudinal study, which offered a much finer-grained analysis of illness course. The researchers haveposited that prior depression leaves a telomere scar even after the episode is over—that is, an “imprint” of past exposure to depression. They raise further questions of profound public health and clinical moment, for example, does telomere shortening contribute to medical comorbidities commonly seen in depressed patients, such as heart disease, diabetes, obesity, and cancer? Finally, they point out that how telomere length relates to treatment response is still unclear, although in the current report LTL was not found to be associated with cumulative antidepressant exposure. In order to place these observations in further context, this commentary will first summarize contemporary understanding of what telomeres are, their function, and their relationship to cellular aging. Secondly, the commentary will offer several observations emerging in the literature of geroscience that account for mechanisms of telomere shortening and the relevance of these mechanisms to common mental disorders like depression. Finally, to recapture a clinical perspective, recent observations relating depression treatment to reductions inmortality secondary to cancerwill be summarized.

(128) Association Between Leukocyte Telomere Length And Erectile Dysfunction In Us Adults: A Cross-Sectional Study Based On 2001-2002 Nhanes Data

Association between leucocyte telomere length and erectile dysfunction in US adults: a secondary study based on 2001-2002 NHANES data

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Associations between Serum Sex Hormone Concentrations and Telomere Length among U.S. Adults, 1999-2002

Telomere length exhibits inverse association with migraine among Americans aged 20–50 years, without implications beyond age 50: a cross-sectional study

Association of Leukocyte Telomere Length in Peripheral Blood Leukocytes with Endometrial Cancer Risk in Caucasian Americans

Association Between Dietary Selenium Intake and Leukocyte Telomere Length in a Nationally Representative Sample of US Adults (OR11-06-19).

Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study

Association of shorter mean telomere length with large artery stiffness in patients with coronary heart disease

The relationship between leukocyte telomere length and risk of depression and anxiety: Evidence from UK Biobank

Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study

The Association between Leucocyte Telomere Length and Survival Outcomes in Patients with Cardiovascular Disease

Association of telomeres length with cardiovascular risk factors and arterial stiffness

Genomic, phenomic, and geographic associations of leukocyte telomere length in the United States

Epigenome-wide association study of leukocyte telomere length.

The associations of leukocyte telomere length and intermediary cardiovascular phenotype with adverse cardiovascular outcomes in the white population

Effects of Inflammation and Depression on Telomere Length in Young Adults in the United States

Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis

Telomere Attrition: A Window Into Common Mental Disorders and Cellular Aging.

Telomere length is inversely correlated with urinary stress hormone levels in healthy controls but not in un-medicated depressed individuals-preliminary findings

Leukocyte Telomere Length Shortening Implies Plaque Instability and Major Adverse Cardiovascular Events in Patients with Angiographically Intermediate Lesions